Drug Type Small molecule drug |
Synonyms JAB BX100, JAB-BX100, JABBX100 |
Target |
Action inhibitors |
Mechanism CD73 inhibitors(5-nucleotidase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | China | 10 Aug 2020 |